Herpesviruses utilize various host factors to establish latent infection, survival, and spread disease in the host.These factors include host cellular machinery, host proteins, gene expression, Games multiple transcription factors, cellular signal pathways, immune cell activation, transcription factors, cytokines, angiogenesis, invasion, and factors promoting metastasis.The knowledge and understanding of host genes, protein products, and biochemical pathways lead to discovering safe and effective antivirals to prevent viral reactivation and spread infection.Here, we focus on the contribution of pro-inflammatory, anti-inflammatory, and resolution lipid metabolites of the arachidonic acid (AA) pathway in the lifecycle of herpesvirus infections.
We discuss how various herpesviruses utilize these lipid pathways to their advantage and how we target them to combat herpesvirus infection.We also summarize recent development in anti-herpesvirus therapeutics and new strategies proposed or under Dryer Maintenance Kit clinical trials.These anti-herpesvirus therapeutics include inhibitors blocking viral life cycle events, engineered anticancer agents, epigenome influencing factors, immunomodulators, and therapeutic compounds from natural extracts.